Skip to main content
High RiskFDAfda-F-0424-2021UNDECLARED ALLERGEN

Anand Far Far (Garlic Sandige) Net Weight 7 oz./200 g package ingredients: rice, wheat flour, garlic, red chilli, refined palm oil and ...

Category
Units Affected
10
Recall Date
March 18, 2021
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0424-2021.

The product was found to contain undeclared yellow# 6, verified via private lab analysis.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0424-2021.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Babco Foods International, Llc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0424-2021.

Babco Foods International, LLC

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Babco Foods International, Llc Recall FAQ

Babco Foods International, Llc is the subject of a beverages safety report: Anand Far Far (Garlic Sandige) Net Weight 7 oz./200 g package ingredients: rice, wheat flour, garlic, red chilli, refined palm oil and .... The notice was published on March 18, 2021 by the U.S. Food and Drug Administration (FDA). Approximately 10 units are potentially affected.